
SI-BONE, Inc.
SIBN
Updated: 05/11/2026, 07:09:49
No historical data available
SI-BONE, Inc. is a medical technology company that develops and markets specialized implantable solutions for musculoskeletal conditions affecting the sacropelvic region. These devices are utilized across the United States and internationally. Its flagship product, iFuse, is a minimally invasive surgical implant system designed to address a range of indications, including sacroiliac joint dysfunction and degeneration, adult spinal deformities, and traumatic fractures of the pelvic ring. Beyond iFuse, the company offers advanced iterations like iFuse-3D. This titanium implant retains the distinctive triangular cross-section of the original iFuse but incorporates a proprietary 3D-printed porous surface and a fenestrated design. Another offering is iFuse-TORQ, a series of 3D-printed threaded implants. These are specifically engineered for treating pelvic fractures and facilitating minimally invasive sacroiliac joint fusion procedures. SI-BONE distributes its products primarily through a dedicated direct sales force, complemented by a network of independent distributors. Established in 2008, the company maintains its corporate headquarters in Santa Clara, California.
No summaries found.
- Share price
- $24.95
- Market cap
- $1.12B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- Laura A. Francis
- Employees
- 376
- IPO date
- 17/10/2018
- Beta
- 0.639
- Last dividend
- $0.00
- Day range
- $23.88 – $25.92
- 52-week range
- $11.48 – $25.92
- 1-day performance
- 4.96%
- 1-year performance
- 117.33%
- Current drawdown (1Y)
- -3.74%
- CIK
- 0001459839
- CUSIP
- 825704109
- ISIN
- US8257041090
- Created
- 07/12/2025, 14:14:10
- Last update
- 05/11/2026, 07:09:49
Track SI-BONE, Inc. with an AI analyst
See which prediction-market events move SIBN, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026
GlobeNewsWire • STOCK • 04/06/2026, 18:09:00
SI-BONE, Inc. (NASDAQ:SIBN) ROIC vs. WACC Analysis: Is it Creating Shareholder Value?
Market Data • Market Data • 01/06/2026, 22:00:03
Analyzing SI-BONE, Inc. (NASDAQ:SIBN) and Medical Device Peers: ROIC vs. WACC Insights
Market Data • Market Data • 22/05/2026, 22:00:05
How Much Upside is Left in Si-Bone (SIBN)? Wall Street Analysts Think 65.27%
Zacks Investment Research • STOCK • 15/05/2026, 12:55:17
SI-BONE, Inc. (SIBN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Seeking Alpha • STOCK • 12/05/2026, 16:50:57
SI-BONE, Inc. (SIBN) Q1 2026 Earnings Call Transcript
Seeking Alpha • STOCK • 12/05/2026, 11:50:44
SiBone Q1 Earnings Call Highlights
MarketBeat • STOCK • 12/05/2026, 00:15:06
SI-BONE, Inc. Reports Financial Results for the First Quarter 2026 and Raises 2026 Guidance
GlobeNewsWire • STOCK • 11/05/2026, 18:09:00
SI-BONE To Report First-Quarter 2026 Financial Results on May 11, 2026
GlobeNewsWire • STOCK • 20/04/2026, 18:09:00
SI-BONE, Inc. (SIBN) Q4 2025 Earnings Call Transcript
Seeking Alpha • STOCK • 23/02/2026, 20:04:59
SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2025 and Issues 2026 Guidance
GlobeNewsWire • STOCK • 23/02/2026, 17:09:00
Earnings Preview: Si-Bone (SIBN) Q4 Earnings Expected to Decline
Zacks Investment Research • STOCK • 16/02/2026, 12:00:22